Jaunty has launched a new series of vape cartridges called Jaunty Ratios. This line-up focuses on enhancing the effects of cannabis through the use of minor cannabinoids. The product range features three distinct formulations that pair THC with minor cannabinoids — including CBG, CBN, and CBD. The blend leverages the Entourage Effect for a more nuanced experience.
Specific blends offered in this range include Zenberry (3:1 THC to CBN), Lucid (1:1 THC to CBD), and Daydream (3:1 THC to CBG). The Jaunty Ratios vape cartridges utilize Quantum Vape™ technology, a first in the United States, which claims to offer quicker onset times and improved flavor profiles. This technology eliminates the risks associated with traditional ceramic heating elements, resulting in consistent vapor quality and no heavy metal contamination. Each cartridge is designed to deliver a one-gram dose with a 510-thread compatibility.
Image Credit: Jaunty
Why This Trend Is Growing
- Minor-cannabinoid Formulations
- Minor-cannabinoid formulations unlock diverse therapeutic benefits by pairing THC with compounds like CBG, CBD, and CBN.
- Entourage Effect Optimization
- Leveraging the Entourage Effect, these products create enhanced consumer experiences by combining multiple cannabinoids for more nuanced effects.
- Advanced Vaporization Technology
- Breakthroughs in vaporization technology, such as Quantum Vape™ technology, promise quicker onset times and superior flavor without heavy metal risks.
Industries Being Reshaped
- Cannabis Products
- Incorporating minor cannabinoids in product formulations expands the therapeutic and recreational potential of cannabis-based products.
- Vape Technology
- Innovations like Quantum Vape™ technology revolutionize the vaping experience, emphasizing safety and enhanced product performance.
- Healthcare and Wellness
- The use of specific minor cannabinoids tailored for different effects opens new avenues for targeted wellness and medicinal applications.
